ArticleLasers in medical science2025
Dose-response and efficacy of 830-nanometer photobiomodulation in healing diabetic foot ulcers: randomized, double-blind, clinical trial protocol.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic foot ulcers (DFUs) cause limitations in physical functioning and performance of activities of daily living (ADLs), accompanied by high emotional burden, anxiety, and depression. Furthermore, persistent and recurrent ulcers, severe amputations, and limitations in ambulation are associated with a significant impact on the quality of life (QOL) and economic burden. Photobiomodulation (PBM) has emerged as a painless, noninvasive, and low-cost option. The biostimulatory and bioinhibitory effects of PBM depend on the parameters used. This double-blind, randomized clinical trial will be conducted at the Integrated Center of Medical Specialties. One Hundred and thirty-six volunteers will be randomized into four groups. GaAlAs 830 nm, 30 mW, in continuous mode (IBRAMED
Indexed as
Identifiers
41021046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.